Home » Topics » Briefs » Other news to note

Other news to note
RSS

Amgen reports active third quarter 2013

Oct. 28, 2013

Cubist completes acquisition of Optimer Pharmaceuticals

Oct. 28, 2013

Bellus Health out-licenses Vivimind and BLU-8499

Oct. 25, 2013

Beactica expands collaboration with Boehringer Ingelheim

Oct. 25, 2013

DBV Technologies and INSERM form collaboration to develop Viaskin for refractory hemophilia A

Oct. 24, 2013

Roche recaps progress of third quarter 2013

Oct. 24, 2013

Gene therapy company Spark Therapeutics spun out of The Children's Hospital of Philadelphia

Oct. 24, 2013

Meda completes acquisition of Acton Pharmaceuticals

Oct. 21, 2013

Bayer Intellectual Property patents new NCX1 inhibitors

Oct. 21, 2013

Johnson & Johnson reviews third quarter 2013

Oct. 17, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...